a Alexander Madio 3 éve
212
Még több ilyen
50% for a parent to pass it to their child
These might never manifest negative phenotypes
Second mutation required may not occur
Phenotypic manifestations may skip generations
Females
Average of 48.4 years
Males
Average of 59.4 years
Would allow for mutation to be passed down
Leads to VHL protein abnormalities
Protein Evolution
pVHL30 is conserved less
pVHL19 is conserved more
Tumor Phylogeny
Some parallel evolution observed
Early Truncal Events
Mutation in chromosome 3
Inactivation of the VHL gene
Evolution of Disease in Particular Organs
Renal Cysts and Carcinomas
May progress to clear cell renal cell carcinomas
Evolve further through additional genetic alterations
Leads to intra-tumour heterogeneity
Following evolutions occur after about 1 to 2 years
First progression after approximately 7 years
Brainstem Hemangioblastomas
Median evolution time of 1.5 years
Progress after 7 years
Cerebellar Hemangioblastomas
3.5-year median evolution time
Pregnancy complications
Stop reproduction
Impact
Not on sequence of evolving disabilities
Not on number of evolving disabilities
Different tumors becoming similar as evolution occurs